Identification and characterization of small-molecule inhibitors of Tie2 kinase

被引:7
|
作者
Liu, Jinqi [1 ]
Lin, Tsung H. [1 ]
Cole, Andrew G. [2 ]
Wen, Rong [3 ]
Zhao, Lian [3 ]
Brescia, Marc-Raleigh [2 ]
Jacob, Biji [1 ]
Hussain, Zahid [2 ]
Appell, Kenneth C. [1 ]
Henderson, Ian [2 ]
Webb, Maria L. [1 ]
机构
[1] Pharmacopeia Inc, Dept Biol, Cranbury, NJ 08512 USA
[2] Pharmacopeia Inc, Dept Chem, Cranbury, NJ 08512 USA
[3] Univ Penn, Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA
关键词
Tie2; small-molecule inhibitor; solubility; stability; CYP450; selectivity; angiogenesis; choroidal neovascularization;
D O I
10.1016/j.febslet.2008.02.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiopoietins and Tie2 receptor were recently identified as an endothelial cell-specific ligand-receptor system that is critical for vascular development and postnatal pathologic angiogenesis by mediating vascular integrity. In this study, we identified a series of small-molecule Tie2 inhibitors, which blocked Ang1-induced Tie2 autophosphorylation and downstream signaling with an IC50 value at 0.3 mu M. Further optimization yields improved selectivity, aqueous solubility, microsomal stability and cytochrome P450 profile for one of the compounds (compound 7). Both compound I and compound 7 inhibit endothelial cell tube formation. Furthermore, in a rat model of Matrigel-induced choroidal neovascularization, compound 7 significantly diminished aberrant vessel growth. Our findings demonstrate a potential clinical benefit by specifically targeting Tie2-mediated angiogenic disorders. (c) 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:785 / 791
页数:7
相关论文
共 50 条
  • [1] Pyridinylimidazole inhibitors of Tie2 kinase
    Semones, Marcus
    Feng, Yanhong
    Johnson, Neil
    Adams, Jerry L.
    Winkler, Jim
    Hansbury, Michael
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (17) : 4756 - 4760
  • [2] Identification and characterization of small-molecule inhibitors of hepsin
    Chevillet, John R.
    Park, Gemma J.
    Bedalov, Antonio
    Simon, Julian A.
    Vasioukhin, Valeri I.
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (10) : 3343 - 3351
  • [3] Identification and Characterization of Novel Small-Molecule SMOX Inhibitors
    Furbish, Amelia B.
    Alford, Ahmed S.
    Burger, Pieter
    Peterson, Yuri K.
    Murray-Stewart, Tracy
    Casero Jr, Robert A.
    Woster, Patrick M.
    MEDICAL SCIENCES, 2022, 10 (03)
  • [4] Identification and characterization of the Cucurbitacins, a novel class of small-molecule inhibitors of Tropomyosin receptor kinase a
    Yueling Zhong
    Hong Xu
    Yi Zhong
    Xuemiao Zhang
    Ting Zeng
    Limei Li
    Gaojie Xu
    Minhui Li
    Jin Liu
    Tai Yang
    BMC Complementary and Alternative Medicine, 19
  • [5] Identification and characterization of the Cucurbitacins, a novel class of small-molecule inhibitors of Tropomyosin receptor kinase a
    Zhong, Yueling
    Xu, Hong
    Zhong, Yi
    Zhang, Xuemiao
    Zeng, Ting
    Li, Limei
    Xu, Gaojie
    Li, Minhui
    Liu, Jin
    Yang, Tai
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 19 (01):
  • [6] Allosteric small-molecule kinase inhibitors
    Wu, Peng
    Clausen, Mads H.
    Nielsen, Thomas E.
    PHARMACOLOGY & THERAPEUTICS, 2015, 156 : 59 - 68
  • [7] Identification of small-molecule inhibitors of USP2a
    Tomala, Marcin D.
    Magiera-Mularz, Katarzyna
    Kubica, Katarzyna
    Krzanik, Sylwia
    Zieba, Bartosz
    Musielak, Bogdan
    Pustula, Marcin
    Popowicz, Grzegorz M.
    Sattler, Michael
    Dubin, Grzegorz
    Skalniak, Lukasz
    Holak, Tad A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 150 : 261 - 267
  • [8] Small-molecule tyrosine kinase inhibitors as radiosensitizers
    Lawrence, TS
    Nyati, MK
    SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (03) : 33 - 36
  • [9] Progress with covalent small-molecule kinase inhibitors
    Zhao, Zheng
    Bourne, Philip E.
    DRUG DISCOVERY TODAY, 2018, 23 (03) : 727 - 735
  • [10] Expression and Characterization of the Receptor Tyrosine Kinase Tie2
    Kennedy, Madison Arza
    Wu, Yunjin
    Grunseth, Adam
    Sohl, Christal D.
    FASEB JOURNAL, 2018, 32 (01):